Davidp Meeker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 8 2%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price rose 8.2% during mid-day trading on Monday . The company traded as high as $39.03 and last traded at $38.61. Approximately 174,823 shares were traded during trading, a decline of 71% from the average daily volume of 604,009 shares. The stock had previously closed at […]

United statesNew yorkJoseph shulmanDavidp meekerWells fargo companyNeedham companyRhythm pharmaceuticals company profileBarclays plcYork state common retirement fundInstitutional investors weigh in on rhythm pharmaceuticalsCharles schwab investment management incRhythm pharmaceuticalsRhythm pharmaceuticals incRhythm pharmaceuticals tradingVictory capital management incSwiss national bank

Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Shares Sold by Primecap Management Co CA

Primecap Management Co. CA reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,052,648 shares of the company’s stock after selling 214,773 shares during the period. […]

United statesNew yorkHunterc smithZurcher kantonalbank zurich cantonalbankDavidp meekerCanaccord genuity groupRhythm pharmaceuticalsQuarter for rhythm pharmaceuticalsNisa investment advisorsNews ratings for rhythm pharmaceuticals dailyRhythm pharmaceuticals profileExchange commissionYork state common retirement fundWells fargo companyGoldman sachs groupNeedham company

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $79 00

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $79 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesDavidp meekerYann mazabraudChina universal asset management coAllspring global investments holdingsRhythm pharmaceuticals company profileRhythm pharmaceuticals trading downAnalyst recommendations for rhythm pharmaceuticalsCanaccord genuity groupWells fargo companyRhythm pharmaceuticalsRhythm pharmaceuticals incGoldman sachs groupHedge funds weigh in on rhythm pharmaceuticalsNeedham companySecurities exchange commission

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $79 00 by Analysts at Canaccord Genuity Group

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $79 00 by Analysts at Canaccord Genuity Group
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkZurcher kantonalbank zurich cantonalbankYann mazabraudDavidp meekerCanaccord genuity groupWells fargo companyRhythm pharmaceuticalsRhythm pharmaceuticals stock downAnalyst recommendations for rhythm pharmaceuticalsRhythm pharmaceuticals incChina universal asset management coRhythm pharmaceuticals company profileSecurities exchange commissionNisa investment advisorsNews ratings for rhythm pharmaceuticals daily

Rhythm Pharmaceuticals (NASDAQ:RYTM) Releases Earnings Results, Misses Estimates By $0 01 EPS

Rhythm Pharmaceuticals (NASDAQ:RYTM) Releases Earnings Results, Misses Estimates By $0 01 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesYann mazabraudDavidp meekerRhythm pharmaceuticals incNeedham companyInsider activity at rhythm pharmaceuticalsGoldman sachs groupWells fargo companyEarnings history for rhythm pharmaceuticalsRhythm pharmaceuticals stock performanceSecurities exchange commissionNews ratings for rhythm pharmaceuticals dailyRhythm pharmaceuticalsGet free reportExchange commissionWells fargo